To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T ...

BioPharm International® spoke with Lun Xin, associate director at WuXi Biologics, about high-concentration biologics and some of the biggest challenges associated with their formulation.

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the release of its 2024 Sustainability Report, ...

NORTH CHICAGO, IL, USA I April 24, 2025 I AbbVie (NYSE: ABBV) today announced submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ...

Shares fall 3.6%. (adria.calatayud@wsj.com) 0550 GMT – Wuxi Biologics’ near-to-medium term growth trajectory looks stable, CGS International analyst Lily Wang says in a note. The company has a ...

Top relative contributors in Q1 included Gentera, Wuxi Biologics and MTN Group. During Q1, we initiated positions in Nova Ljubljanska Banka and Compañía de Minas Buenaventura. Emerging markets ...

offer a differentiated side effect profile compared to biologics. The Big Pharma put the idea to the test in a phase 2 trial that enrolled 221 people with psoriasis to take balinatunfib as a ...

In this article, we are going to take a look at where ADMA Biologics, Inc. (NASDAQ:ADMA) stands against other takeover rumor stocks hedge funds are buying. Hedge funds tend to pile up on a stock ...

Substantial savings opportunities exist by using lower-cost biologics for patients with plaque psoriasis, according to one study. The cost of biologic treatments for patients with plaque psoriasis ...

PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene ...

Firm commitment to tackling climate change in support of United Nations Sustainable Development GoalsEarth Day 2025 - Our ...